LFCR
LIFECORE BIOMEDICAL, INC. \DE\
Key Financials
Net Income
$-38717000
↓ 422.3%
Operating Income
$-17245000
↓ 95.0%
Gross Profit
$40.3M
↓ 3.7%
EPS (Diluted)
$-1.27
↓ 496.9%
Total Assets
$239.3M
↓ 5.8%
Total Liabilities
$191.9M
↓ 4.1%
Shareholders' Equity
$1.3M
↓ 88.2%
Cash & Equivalents
$8.3M
↓ 2.3%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| SCHEDULE 13D/A | 7/2/2026 | View on SEC |
| 8-K | 7/2/2026 | View on SEC |
| SCHEDULE 13D/A | 7/2/2026 | View on SEC |
| 4 | 6/8/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | LFCR |
| Company Name | LIFECORE BIOMEDICAL, INC. \DE\ |
| CIK | 1005286 |
| Sector | Pharmaceutical Preparations |
| Industry | Accelerated filer Smaller reporting company |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 0525 |
| State of Incorporation | DE |
| Phone | 9523684300 |